Ganglioneuroblastoma presenting as dilated cardiomyopathy

Archives of Disease in Childhood

Volumn 88, Issue 2, 2003, Pages 162-164

  Lee, Y H ^a   Lee, H D ^a   Lee, Y A ^a   Lee, Y S ^a   Jung, J A ^a   Hwang, G G ^a   Jung, G W ^a   Kim, D W ^a   Roh, M S ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMRINONE; CAPTOPRIL; CARNITINE; DIURETIC AGENT; DOPAMINE;

ABDOMINAL MASS; ARTICLE; CARDIOMEGALY; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART DILATATION; HUMAN; NEUROBLASTOMA; PATHOLOGY; PRIORITY JOURNAL;

ADRENAL GLAND NEOPLASMS; CARDIOMYOPATHY, DILATED; FEMALE; GANGLIONEUROBLASTOMA; HUMANS; INFANT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037311596     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.88.2.162     Document Type: Article

References (8)

1. Imperato-McGinley J, Gautier T, Ehlers K, et al. Reversibility of catecholamine induced dilated cardiomyopathy in a child with pheochromocytoma. N Engl J Med 1987;316:793-7.
2. Roberts KB, Freeman JM. Cerebella ataxia and "occult neuroblastoma" without opsoclonus. Pediatrics 1975;56:464-5.
3. El Shafie M, Samuel D, Klippel CH, et al. Intractable diarrhea in children with VIP-secreting ganglioneuroblastomas. J Pediatr Surg 1983;18:34-6.
4. Qualman SJ, O'Dorisio MS, Fleshman DJ, et al. Neuroblastoma: correlation of neuropeptide expression in tumor tissue with other prognostic factors. Cancer 1992;70:2005-12.
5. Rosti L, Festa P, Corbetta C. Rapid reversal of dilated cardiomyopathy following removal of neuroblastoma. Cardiol Young 1999;9:519-21.
6. Joseph T, Olivier B, Magnier S, et al. Cardiomyopathy induced by catecholamines in neuroblastoma. Arch Pediatr 1997;4:32-5.
7. Sendo D, Katsuura M, Akiba K, et al. Severe hypertension and cardiac failure associated with neuroblastoma: a case report. J Pediatr Surg 1996;31:1688-90.
8. Chen L, Rc RN, Prakash O, et al. Angiotensin-converting enzyme inhibition reduces neuroblastoma cell growth rate. PSEBM 1991;196:280-3.